PCN104 COST-EFFECTIVENESS OF ERLOTINIB IN THE TREATMENT OF ADVANCED NON SMALL CELL LUNG CANCER IN CHINA
Abstract
Authors
W Chen F Sheng N Qiao
W Chen F Sheng N Qiao
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now